NCT02033616 - Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 18, 2017

Primary Completion Date

March 15, 2022

Study Completion Date

March 31, 2023

Conditions

Stage III Ovarian CarcinomaStage IV Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma

Interventions

BIOLOGICAL

AVOVA-1

Comparison of a cancer treatment containing autologous dendritic cells loaded with tumor associated antigens (TAA) from autologous self-renewing tumor cells vs. a cancer treatment containing autologous immune cells.

BIOLOGICAL

Trial Locations (6)

80045

University of Colorado Hospital - Cancer Center, Aurora

91505

Disney Family Cancer Center, Burbank

92037

Scripps Health, La Jolla

92093

UC San Diego, Moores Cancer Center, La Jolla

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

92868

UC Irvine, Chao Family Comprehensive Cancer Center, Orange